Effect of Second mitochondria-derived activator of caspase in combination with Docetaxel on lung cancer cell A549.

Li, Xiao-Mei; Yang, Yong-Wei; Maimaitiyiming, Xiao-Kaiti; Jin, Cheng-Yu; Zou, Wen; Jiang, Yu-Hua; Peng, Chuan-Liang

Li, Xiao-Mei; Yang, Yong-Wei; Maimaitiyiming, Xiao-Kaiti; Jin, Cheng-Yu; Zou, Wen; Jiang, Yu-Hua; Peng, Chuan-Liang.

Afiliação

Li XM; Cancer Center of The Second Hospital, Shandong University Jinan, China.
Yang YW; Xinjiang Uygur Autonomous Region People's Hospital Urumqi, China.
Maimaitiyiming XK; Xinjiang Uygur Autonomous Region People's Hospital Urumqi, China.
Jin CY; Xinjiang Uygur Autonomous Region People's Hospital Urumqi, China.
Zou W; Department of Pharmacology, The Second Hospital, Shandong University Jinan, China.
Jiang YH; Cancer Center of The Second Hospital, Shandong University Jinan, China.
Peng CL; Department of Thoracic, The Second Hospital, Shandong University Jinan, China.

Int J Clin Exp Med ; 8(5): 7613-9, 2015.

Article em En | MEDLINE | ID: mdl-26221307

Palavras-chave

Docetaxel; Second mitochondria-derived activator of caspase; apoptosis; cloning ability; lung cancer

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Int J Clin Exp Med Ano de publicação: 2015 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google